Genomtec S.A. (WSE:GMT)
Poland
· Delayed Price · Currency is PLN 6.75
-0.09 (-1.32%)
Jun 27, 2025, 4:14 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 101.69 million as of June 27, 2025. Its market cap has decreased by -36.40% in one year.
Market Cap
101.69M
Enterprise Value
90.43M
Revenue
6.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
6.75
Market Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 101.69M, a decrease of -8.01%. That is a compound annual growth rate of -1.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 101.69M | -2.90% |
| Dec 30, 2024 | 104.73M | -21.25% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.05B |
| Synektik Spólka Akcyjna | 1.77B |
| Voxel | 1.58B |
| Celon Pharma | 1.17B |
| Ryvu Therapeutics | 700.54M |
| Centrum Medyczne ENEL-MED | 559.95M |
| Selvita | 526.80M |
| Bioceltix | 524.95M |